What is a therapeutic duplication on the PTCE?
Knowledge Area 1.2 covers two drugs that treat the same condition through the same or overlapping pathways. The technician is expected to recognize the overlap and flag it for the pharmacist. Combining an ACE inhibitor with an ARB is a common example of same-pathway duplication.
PTCB PTCE Content Outline (effective January 2026), Knowledge Area 1.2
Same domain
- What brand, generic, and classification knowledge is on the PTCE?
- Which interaction types appear on the PTCE?
- How are strengths, doses, and dosage forms tested?
- What special handling and administration instructions are in scope?
- How does the PTCE treat side effects, adverse effects, and allergies?
- Are medication indications on the PTCE?
- What stability facts are tested for insulin, suspensions, and injectables?
- What storage conditions does the PTCE expect?
- Is reconstitution on the current PTCE?